Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

Quan Dong Nguyen, Syed Mahmood Shah, Jeffery S. Heier, Diana V. Do, Jennifer Lim, David Boyer, Prema Abraham, Peter A. Campochiaro

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study'. Together they form a unique fingerprint.

Medicine & Life Sciences